Multiomic Profiling for Colorectal Cancer Detection
Colorectal Cancer (Early Detection)
Pre-clinicalActive
Key Facts
About Tagomics
Tagomics is a private, pre-revenue diagnostics company developing a proprietary multiomic profiling platform for disease detection and diagnosis. Based in Cambridge, UK, the company leverages epigenetic, genetic, and fragmentomic data combined with machine learning to identify biomarkers, with an initial focus on colorectal cancer. Key recent developments include an £860k Innovate UK grant and a co-marketing agreement with Agilent, positioning it to commercialize a unified workflow for comprehensive genomic profiling.
View full company profile